GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CStone Pharmaceuticals 2616.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

5.41

+1.12%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About CStone Pharmaceuticals

Its shares trade on HKEX under the ticker 2616.HK. It has been listed since 26 February 2019. In the fiscal year to 31 December 2025, it reported revenue of CN¥314.0m and a net loss of CN¥508.9m. At that date it held total assets of CN¥1.58bn and shareholders' equity of CN¥718.6m.

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
26 Feb 2019
Employees
220

Leadership

Pay as last reported

  • Dr. Wei LiNon-Executive Chairman of the Board
  • Dr. Jianxin YangChief Executive Officer, Executive Director, since 2016
  • Dr. Jingrong LiSenior Vice President, Chief Technology Officer
  • Dr. Ngai Chiu TseSenior Vice President, Chief Scientific Officer
  • Mr. Sanhu WangSenior Vice President of Government and Regulatory Affairs
  • Mr. Jun ChengVice President - Finance
  • Dr. Josh ZhouGreater China General Manager and Head of Commercial
  • Mr. Michael ChoiChief Business Officer
  • Ms. Weicong NiJoint Company Secretary
  • Ms. Mei Yee YungJoint Company Secretary
  • Mr. Kenneth HitchnerNon-Executive DirectorCN¥269,000
  • Mr. Edward HuNon-Executive Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.